Aura Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aura Biosciences generated cash of -$63,847,000, which is less than the previous year. Cash used in financing activities reached the amount of $97,290,000 last year. Net change in cash is therefore -$80,520,000.
Cash Flow
| 2019 | -20.66M | -2.22M | 39.72M |
|---|---|---|---|
| 2020 | -24.32M | -771K | 10.03M |
| 2021 | -32.41M | -2.12M | 166.25M |
| 2022 | -54.60M | -67.86M | 95.62M |
| 2023 | -63.84M | -113.96M | 97.29M |
AURA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 122.37M | 149.21M | 17.48M | 32.54M | 15.70M |
Operating activities | |||||
Net income | -76.40M | -58.76M | -35.25M | -22.20M | -24.2M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.29M | 1.17M | 831K | 831K | 509K |
Stock-based compensation expense | 8.77M | 6.41M | 2.30M | 736K | 507K |
| Deferred income tax benefit | 8.77M | 6.41M | 2.30M | 736K | 507K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.04M | 340K | 1.05M | -1.72M | 1.04M |
Cash generated by operating activities | -63.84M | -54.60M | -32.41M | -24.32M | -20.66M |
Investing activities | |||||
Purchases Of Investments | -233.65M | -119.78M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -709K | -1.09M | -2.12M | -771K | -2.22M |
Acquisitions Net | 0 | 66.77K | 0 | 0 | 0 |
Cash generated by investing activities | -113.96M | -67.86M | -2.12M | -771K | -2.22M |
Financing activities | |||||
Common Stock Issued | 3.17M | 8.54M | 78.69M | 10.07M | 39.76M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -13K |
Repayments of term debt | 0 | 0 | 0 | -34K | -37K |
Cash used in financing activities | 97.29M | 95.62M | 166.25M | 10.03M | 39.72M |
Net Change In Cash | -80.52M | -26.84M | 131.72M | -15.05M | 16.83M |
Cash at end of period | 41.85M | 122.37M | 149.21M | 17.48M | 32.54M |
| Data source | Data source | Data source |